Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer.
Inna Markovna ChenAstrid Z JohansenChristian DehlendorffBenny V JensenStig E BojesenPer PfeifferJon K BjerregaardSvend Erik NielsenFahimeh AndersenNiels Henrik HollanderMette K YilmazLouise S RasmussenJulia S JohansenPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)
Assessment of systemic inflammation via measurements of IL6, YKL-40, and CRP may be important for pancreatic cancer prognostication.